HighRes and Waters Partner to Accelerate Drug Discovery with Robotic Automation
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow…
Merck KGaA and Versant Ventures Launch Saturnus Bio to Advance Rare Genetic Cardiomyopathy Treatments
Merck KGaA Teams With Saturnus Bio to Build Precision Cardiology Portfolio for Rare Genetic Cardiomyopathies Merck KGaA, Darmstadt, Germany has entered a strategic research-stage collaboration with Saturnus Bio, a biotechnology…
Cynosure Lutronic’s XERF Gains Rapid Adoption Across North America as Leading Monopolar RF Platform
Cynosure Lutronic’s XERF Surpasses 2,000 Installations Worldwide, Highlighting Growing Demand for Non-Invasive Skin Tightening Cynosure Lutronic has reached a new commercial milestone for XERF™, its multifrequency monopolar radiofrequency platform for…
VectorBuilder and MaxCyte Partner to Advance Clinical-Grade Cell Engineering
VectorBuilder and MaxCyte Partner to Develop Next-Generation Non-Viral Gene Delivery Platform for Ex Vivo Cell Therapies VectorBuilder and MaxCyte have entered into a strategic partnership aimed at developing a next-generation…
Dexcom Expands Its Vision for Glucose Biosensing for All
Dexcom Expands Access to Glucose Biosensing With Pediatric Clearance for Stelo and New App Rollout Plans DexCom, Inc. is broadening its push into preventive and personalized metabolic health with a…
Vyriad Unveils Leadership Changes to Support Next Phase of Growth
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on…
Alpha Cognition Appoints Dr. Robert Wills as Chairman of the Board
Alpha Cognition Appoints Robert Wills as Chairman of the Board as Company Advances ZUNVEYL Launch and Neurodegenerative Pipeline Alpha Cognition Inc. has announced a key leadership transition at the board…
DiaMedica Begins Dosing Patients in Phase 2 DM199 Trial for Fetal Growth Restriction
DiaMedica Begins Phase 2 Clinical Evaluation of DM199 in Fetal Growth Restriction as First Patients Receive Treatment DiaMedica Therapeutics has reached an important clinical milestone in its effort to address…
HistoSonics Secures New Financing Round Backed by Yosemite and Other Strategic Investors
HistoSonics Raises New Financing to Expand Histotripsy Platform Across Solid Tumors HistoSonics, the medical technology company behind the Edison® Histotripsy System, has closed a new financing round backed by Reed…
Arrowhead Wins EU Approval for REDEMPLO in Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals Wins EU Approval for REDEMPLO® to Lower Triglycerides in Adults with Familial Chylomicronemia Syndrome Arrowhead Pharmaceuticals has secured an important regulatory milestone in Europe with the European Commission’s…
Trace Neuroscience Launches Global Clinical Program for ALS Therapy TRCN-1023
Trace Neuroscience Launches Global Clinical Development Program for TRCN-1023 in ALS Trace Neuroscience, Inc., a biopharmaceutical company focused on advancing genomic medicine for people living with neurodegenerative diseases, has announced…
Biocom’s 2026 Report Highlights California Life Science Industry Strength
Biocom Report Highlights California Life Science Industry’s $394 Billion Economic Impact and Resilience in 2025 Biocom, the largest life science membership association representing companies across California and other major life…